D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.93% |
| 2 | Consumer Discretionary | 10.48% |
| 3 | Healthcare | 8.56% |
| 4 | Communication Services | 8.41% |
| 5 | Financials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1951
PUT
Lincoln National
LNC
$8.19B
| $3.74M | ﹤0.01% |
60,000
-68,200
| -53% | -$3.77M |
|
1952
Hackett Group
HCKT
$266M
| $3.73M | ﹤0.01% |
227,795
+2,787
| +1% | +$43.1K |
|
1953
Caesarstone
CSTE
$71.6M
| $3.73M | ﹤0.01% |
271,501
+53,738
| +25% | +$711K |
|
1954
Marriott Vacations Worldwide
VAC
$3.52B
| $3.73M | ﹤0.01% |
21,391
+9,099
| +74% | +$1.42M |
|
1955
Bio-Techne
TECH
$11.2B
| $3.71M | ﹤0.01% |
38,908
-4,576
| -11% | -$417K |
|
1956
Xos
XOS
$28.3M
| $3.71M | ﹤0.01% |
+12,482
| New | +$4.05M |
|
1957
CALL
Nutrien
NTR
$33.3B
| $3.71M | ﹤0.01% |
68,900
| – | – |
|
1958
PUT
BioMarin Pharmaceuticals
BMRN
$12B
| $3.7M | ﹤0.01% |
49,000
+9,000
| +23% | +$735K |
|
1959
Replimune Group
REPL
$449M
| $3.7M | ﹤0.01% |
121,257
+14,098
| +13% | +$528K |
|
|
DISCK
1960
PUT
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $3.69M | ﹤0.01% |
+100,000
| New | +$4.24M |
|
1961
PUT
Vodafone
VOD
$37.7B
| $3.69M | ﹤0.01% |
200,000
| – | – |
|
1962
CALL
Rio Tinto
RIO
$149B
| $3.68M | ﹤0.01% |
47,400
-72,600
| -61% | -$5.95M |
|
1963
CALL
Lemonade
LMND
$4.77B
| $3.68M | ﹤0.01% |
+39,500
| New | +$5.1M |
|
1964
HealthStream
HSTM
$843M
| $3.68M | ﹤0.01% |
164,570
-46,583
| -22% | -$1.11M |
|
|
HAYN
1965
DELISTED
Haynes International, Inc.
HAYN
| $3.68M | ﹤0.01% |
123,902
-24,143
| -16% | -$651K |
|
1966
Lamar Advertising Co
LAMR
$16.5B
| $3.67M | ﹤0.01% |
39,075
-122,218
| -76% | -$10.8M |
|
|
SCHW
1967
CALL
Charles Schwab
SCHW
$184B
| $3.67M | ﹤0.01% |
56,300
-43,700
| -44% | -$2.65M |
|
1968
Deluxe
DLX
$1.25B
| $3.66M | ﹤0.01% |
87,283
-114,710
| -57% | -$4.32M |
|
1969
Constellium
CSTM
$3.96B
| $3.66M | ﹤0.01% |
248,935
+53,672
| +27% | +$771K |
|
1970
Safety Insurance
SAFT
$1.51B
| $3.66M | ﹤0.01% |
43,409
+14,841
| +52% | +$1.19M |
|
1971
SLR Investment Corp
SLRC
$708M
| $3.65M | ﹤0.01% |
205,394
+105,129
| +105% | +$1.93M |
|
1972
SPX Corp
SPXC
$10.2B
| $3.64M | ﹤0.01% |
62,465
+6,024
| +11% | +$343K |
|
|
SUNL
1973
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
| $3.63M | ﹤0.01% |
+17,335
| New | +$4.06M |
|
1974
NNN REIT
NNN
$9.37B
| $3.61M | ﹤0.01% |
81,989
-84,816
| -51% | -$3.55M |
|
1975
CALL
Realty Income
O
$61.3B
| $3.59M | ﹤0.01% |
58,411
-55,315
| -49% | -$3.28M |
|
Similar funds
D.E. Shaw & Co's Q1 2021 Portfolio in Review
As of Q1 2021, D.E. Shaw & Co held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
D.E. Shaw & Co withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Baidu worth $627M.
- D.E. Shaw & Co's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- D.E. Shaw & Co added most to Tesla in Q1 2021, an estimated $862M increase.
- D.E. Shaw & Co's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- D.E. Shaw & Co fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- D.E. Shaw & Co's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- D.E. Shaw & Co opened 825 new positions and closed 730 in Q1 2021.
- D.E. Shaw & Co's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.